Aldeyra Therapeutics (ALDX)
(Delayed Data from NSDQ)
$3.27 USD
+0.19 (6.17%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $3.26 -0.01 (-0.31%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.08 | 0.00% |
Earnings Summary
For their last quarter, Aldeyra Therapeutics (ALDX) reported earnings of -$0.08 per share, beating the Zacks Consensus Estimate of $-0.21 per share. This reflects a positive earnings surprise of 61.90%. Look out for ALDX's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.08 per share, reflecting a year-over-year increase of 70.37%.
Earnings History
Price & Consensus
Zacks News for ALDX
Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?
ALDX: What are Zacks experts saying now?
Zacks Private Portfolio Services